Skip to content
10-Q/A

Quarterly Report

CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC. CBIH

0001683168-25-003345

← back to feed
Filed
May 9, 2025 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · May 9, 2025 10.93B sh
Shares Diluted Q3 2025 · Feb 28, 2025 10.73B sh
Shares Diluted Q3 2025 · Feb 28, 2025 10.57B sh
Shares Diluted Q3 2025 · Feb 29, 2024 10.37B sh
Shares Diluted Q3 2025 · Feb 29, 2024 10.32B sh
Operating Cash Flow Q3 2025 · Feb 28, 2025 −$185.32K
Operating Cash Flow Q3 2025 · Feb 29, 2024 −$304.94K
Long Term Debt Q3 2025 · Feb 28, 2025 $249.5K
Long Term Debt Q3 2025 · May 31, 2024 $249.36K
Short Term Debt Q3 2025 · Feb 28, 2025 $14.59K
Short Term Debt Q3 2025 · May 31, 2024 $7.05K
Stockholders Equity restated Q3 2025 · Feb 28, 2025 −$1.23M
Stockholders Equity restated Q3 2025 · Nov 30, 2024 −$1.16M
Stockholders Equity restated Q3 2025 · Aug 31, 2024 −$1.06M
Stockholders Equity Q3 2025 · May 31, 2024 −$1.08M
Stockholders Equity Q3 2025 · Feb 29, 2024 −$976.08K
Stockholders Equity Q3 2025 · Nov 30, 2023 −$841.89K
Stockholders Equity Q3 2025 · Aug 31, 2023 −$717.46K
Stockholders Equity Q3 2025 · May 31, 2023 −$591.67K
Current Liabilities Q3 2025 · Feb 28, 2025 $970.06K
Current Liabilities Q3 2025 · May 31, 2024 $881.91K
Total Liabilities Q3 2025 · Feb 28, 2025 $1.24M
Total Liabilities Q3 2025 · May 31, 2024 $1.14M
Current Assets Q3 2025 · Feb 28, 2025 $3.79K
Current Assets Q3 2025 · May 31, 2024 $21.49K
Total Assets Q3 2025 · Feb 28, 2025 $14.89K
Total Assets Q3 2025 · May 31, 2024 $57.16K
Eps Diluted Q3 2025 · Feb 28, 2025 $0.00
Eps Diluted Q3 2025 · Feb 28, 2025 $0.00
Eps Diluted Q3 2025 · Feb 29, 2024 $0.00
Eps Diluted Q3 2025 · Feb 29, 2024 −$0.00
Eps Basic Q3 2025 · Feb 28, 2025 $0.00
Eps Basic Q3 2025 · Feb 28, 2025 $0.00
Eps Basic Q3 2025 · Feb 29, 2024 $0.00
Eps Basic Q3 2025 · Feb 29, 2024 −$0.00
Sga Expense Q3 2025 · Feb 28, 2025 $50.17K
Sga Expense Q3 2025 · Feb 28, 2025 $151.6K
Sga Expense Q3 2025 · Feb 29, 2024 $25.29K
Sga Expense Q3 2025 · Feb 29, 2024 $114.01K
Net Income Q3 2025 · Feb 28, 2025 −$181.24K
Net Income Q3 2025 · Feb 28, 2025 −$337.08K
Net Income Q3 2025 · Nov 30, 2024 −$79.53K
Net Income Q3 2025 · Aug 31, 2024 −$76.31K
Net Income Q3 2025 · Feb 29, 2024 −$209.19K
Net Income Q3 2025 · Feb 29, 2024 −$515.41K
Net Income Q3 2025 · Nov 30, 2023 −$124.43K
Net Income Q3 2025 · Aug 31, 2023 −$181.79K
Operating Income Q3 2025 · Feb 28, 2025 −$129.23K
Operating Income Q3 2025 · Feb 28, 2025 −$286.47K
Operating Income Q3 2025 · Feb 29, 2024 −$159.97K
Operating Income Q3 2025 · Feb 29, 2024 −$456.51K
Gross Profit Q3 2025 · Feb 28, 2025 −$4.47K
Gross Profit Q3 2025 · Feb 28, 2025 $232.51K
Gross Profit Q3 2025 · Feb 29, 2024 $24.6K
Gross Profit Q3 2025 · Feb 29, 2024 $137.26K
Cost Of Revenue Q3 2025 · Feb 28, 2025 $19.4K
Cost Of Revenue Q3 2025 · Feb 28, 2025 $35.56K
Cost Of Revenue Q3 2025 · Feb 29, 2024 $11.81K
Cost Of Revenue Q3 2025 · Feb 29, 2024 $35.72K
Revenue Q3 2025 · Feb 28, 2025 $14.93K
Revenue Q3 2025 · Feb 28, 2025 $268.07K
Revenue Q3 2025 · Feb 29, 2024 $36.41K
Revenue Q3 2025 · Feb 29, 2024 $172.98K